ArticleJournal for immunotherapy of cancer2024

Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma.

Matthew R Kudelka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.